• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

息肉状脉络膜血管病变:白种人中一种常见的新生血管性年龄相关性黄斑变性类型。

Polypoidal choroidal vasculopathy: a common type of neovascular age-related macular degeneration in Caucasians.

作者信息

Yadav Sohraab, Parry David G, Beare Nick A V, Pearce Ian A

机构信息

St. Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK.

出版信息

Br J Ophthalmol. 2017 Oct;101(10):1377-1380. doi: 10.1136/bjophthalmol-2016-310074. Epub 2017 Mar 7.

DOI:10.1136/bjophthalmol-2016-310074
PMID:28270486
Abstract

AIMS

To describe the prevalence of polypoidal choroidal vasculopathy (PCV) in a Caucasian population with neovascular age-related macular degeneration (NAMD).

METHODS

All patients referred to a city AMD service over a 2-year period underwent imaging including Indocyanine Green Angiography at baseline. A panel of experts confirmed the patients with NAMD and diagnosed the lesion type including PCV. The proportion of Caucasian patients with PCV was identified. Two authors independently reviewed clinical imaging and recorded data of patients with PCV on lesion characteristics. Further information including treatments received and visual acuity at different time points was analysed.

RESULTS

A total of 492 patients were diagnosed with NAMD during the 2-year study period. Of these patients, 204 had occult lesions (41.5%). PCV was identified in 45 patients (22.1% of occult NAMD and 9.1% of all NAMD). 23 patients received anti-vascular endothelial growth factor (VEGF) monotherapy, 8 received verteporfin photodynamic therapy (PDT) monotherapy and the remaining 14 patients were managed with combined PDT and anti-VEGF treatment.

CONCLUSIONS

The prevalence of PCV in Caucasians is higher than previously reported. Indocyanine Green Angiography should be a standard investigation for all new patients with NAMD, particularly those with occult NAMD, to avoid missing this important subset.

摘要

目的

描述息肉状脉络膜血管病变(PCV)在患有新生血管性年龄相关性黄斑变性(NAMD)的白种人群中的患病率。

方法

在两年期间转诊至某城市AMD服务机构的所有患者在基线时均接受了包括吲哚菁绿血管造影在内的影像学检查。一组专家对NAMD患者进行了确诊,并对病变类型(包括PCV)进行了诊断。确定了患有PCV的白种患者的比例。两位作者独立复查了临床影像学资料,并记录了PCV患者的病变特征数据。分析了包括所接受的治疗以及不同时间点的视力等进一步信息。

结果

在为期两年的研究期间,共有492例患者被诊断为NAMD。在这些患者中,204例有隐匿性病变(41.5%)。45例患者被确诊为PCV(占隐匿性NAMD的22.1%,占所有NAMD的9.1%)。23例患者接受了抗血管内皮生长因子(VEGF)单药治疗,8例接受了维替泊芬光动力疗法(PDT)单药治疗,其余14例患者接受了PDT与抗VEGF联合治疗。

结论

白种人中PCV的患病率高于先前报道。吲哚菁绿血管造影应作为所有新诊断的NAMD患者,尤其是隐匿性NAMD患者的标准检查,以避免遗漏这一重要亚组。

相似文献

1
Polypoidal choroidal vasculopathy: a common type of neovascular age-related macular degeneration in Caucasians.息肉状脉络膜血管病变:白种人中一种常见的新生血管性年龄相关性黄斑变性类型。
Br J Ophthalmol. 2017 Oct;101(10):1377-1380. doi: 10.1136/bjophthalmol-2016-310074. Epub 2017 Mar 7.
2
Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy.息肉状脉络膜血管病变继发的难治性新生血管性年龄相关性黄斑变性
Am J Ophthalmol. 2009 Jul;148(1):70-8.e1. doi: 10.1016/j.ajo.2009.02.012. Epub 2009 Apr 29.
3
Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.用于治疗伴有息肉样脉络膜新生血管的新生血管性年龄相关性黄斑变性的选择性光动力疗法
Retina. 2007 Sep;27(7):825-31. doi: 10.1097/IAE.0b013e31804b3f70.
4
One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.日本患者年龄相关性黄斑变性和息肉样脉络膜血管病变的光动力疗法一年期疗效
Ophthalmology. 2008 Jan;115(1):141-6. doi: 10.1016/j.ophtha.2007.02.031. Epub 2007 Jun 20.
5
The Use of Vascular Endothelial Growth Factor Inhibitors and Complementary Treatment Options in Polypoidal Choroidal Vasculopathy: A Subtype of Neovascular Age-Related Macular Degeneration.血管内皮生长因子抑制剂的应用及息肉样脉络膜血管病变的补充治疗选择:一种新生血管性年龄相关性黄斑变性的亚型。
Int J Mol Sci. 2018 Sep 3;19(9):2611. doi: 10.3390/ijms19092611.
6
Anti-Vascular Endothelial Growth Factor Resistance in Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy.渗出性黄斑变性和息肉状脉络膜血管病变中的抗血管内皮生长因子耐药性
Ophthalmol Retina. 2019 Sep;3(9):744-752. doi: 10.1016/j.oret.2019.04.018. Epub 2019 Apr 24.
7
Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2.非 ICGA 治疗标准用于治疗脉络膜息肉样血管病变的抗 VEGF 反应不佳:APOIS PCV 工作组报告 2。
Ophthalmol Retina. 2021 Oct;5(10):945-953. doi: 10.1016/j.oret.2021.04.002. Epub 2021 Apr 16.
8
Effectiveness of polypoidal lesion-selective photodynamic therapy with intravitreal antivascular endothelial growth factor for polypoidal choroidal vasculopathy.多灶性脉络膜血管病变的息肉样病变选择性光动力疗法联合玻璃体内抗血管内皮生长因子治疗的疗效。
Jpn J Ophthalmol. 2020 May;64(3):265-270. doi: 10.1007/s10384-020-00734-3. Epub 2020 Mar 23.
9
CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.光学相干断层扫描高反射灶与新生血管性年龄相关性黄斑变性及息肉样脉络膜血管病变抗VEGF治疗后视觉预后的相关性
Retina. 2016 Mar;36(3):465-75. doi: 10.1097/IAE.0000000000000645.
10
EVEREST study report 4: Fluorescein angiography features predictive of polypoidal choroidal vasculopathy.EVEREST 研究报告 4:荧光素血管造影特征预测息肉样脉络膜血管病变。
Clin Exp Ophthalmol. 2019 Jul;47(5):614-620. doi: 10.1111/ceo.13464. Epub 2019 Feb 10.

引用本文的文献

1
Polypoidal choroidal vasculopathy features among Filipino eyes with neovascular AMD: application of the Asia Pacific Ocular Smaging Society non-ICGA criteria.菲律宾新生血管性年龄相关性黄斑变性患者眼中的息肉状脉络膜血管病变特征:亚太眼成像学会非吲哚青绿血管造影标准的应用
Int Ophthalmol. 2025 Aug 25;45(1):351. doi: 10.1007/s10792-025-03715-y.
2
Expert Panel Consensus for Optimizing Outcomes in Neovascular Age-Related Macular Degeneration in the Context of Suboptimal Response to a Biosimilar: The Role of Aflibercept.在对生物类似药反应欠佳的情况下优化新生血管性年龄相关性黄斑变性治疗效果的专家小组共识:阿柏西普的作用
Clin Ophthalmol. 2024 Nov 2;18:3133-3142. doi: 10.2147/OPTH.S481772. eCollection 2024.
3
Real world treatment outcomes in polypoidal choroidal vasculopathy in a Caucasian population of British ethnicity.
在英国白种人群体中的息肉样脉络膜血管病变的真实世界治疗结果。
Eye (Lond). 2024 Nov;38(16):3072-3076. doi: 10.1038/s41433-024-03221-y. Epub 2024 Jul 12.
4
Imaging characterization of the fellow eye in patients with unilateral polypoidal choroidal vasculopathy.单侧息肉状脉络膜血管病变患者对侧眼的影像学特征。
Int Ophthalmol. 2024 Mar 1;44(1):122. doi: 10.1007/s10792-024-03048-2.
5
Clinical variations of polypoidal choroidal vasculopathy: A cohort study from Japan and the USA.息肉样脉络膜血管病变的临床变异:来自日本和美国的队列研究。
Sci Rep. 2023 Mar 23;13(1):4800. doi: 10.1038/s41598-023-31649-x.
6
Analysis of Systemic and Serum Risk Factors in Patients with Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.年龄相关性黄斑变性和息肉状脉络膜血管病变患者的全身及血清危险因素分析
Ophthalmol Ther. 2023 Apr;12(2):1033-1044. doi: 10.1007/s40123-023-00650-y. Epub 2023 Jan 21.
7
European Prevalence of Polypoidal Choroidal Vasculopathy: A Systematic Review, Meta-Analysis, and Forecasting Study.欧洲息肉样脉络膜血管病变的患病率:一项系统评价、荟萃分析和预测研究。
J Clin Med. 2022 Aug 16;11(16):4766. doi: 10.3390/jcm11164766.
8
Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort.比较光动力疗法联合玻璃体内雷珠单抗或阿柏西普治疗欧洲队列中息肉样脉络膜血管病变的 3 年疗效。
Graefes Arch Clin Exp Ophthalmol. 2022 Nov;260(11):3533-3542. doi: 10.1007/s00417-022-05724-4. Epub 2022 Jun 9.
9
Real-world outcomes of combined therapy of photodynamic therapy with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.光动力疗法联合抗血管内皮生长因子治疗息肉状脉络膜血管病变的真实世界结局。
Eye (Lond). 2022 Oct;36(10):1934-1939. doi: 10.1038/s41433-021-01773-x. Epub 2021 Sep 28.
10
Idiopathic polypoidal choroidal vasculopathy: a review of literature with clinical update on current management practices.特发性息肉状脉络膜血管病变:文献复习及现行治疗方法的临床更新。
Int Ophthalmol. 2021 Feb;41(2):753-765. doi: 10.1007/s10792-020-01620-0. Epub 2020 Oct 20.